Ostrom QT, Gittleman H, Truitt G, Boscia A, Kruchko C, Barnholtz-Sloan JS, CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2011–2015, Neuro Oncol (2018) 20 (suppl 4), October 2018. See link under Reports and Tables.

Makkar N, Ostrom Q, Kruchko C, Barnholtz-Sloan JS, A comparison of relative survival and cause-specific survival methods to measure net survival in cancer populations, Cancer Medicine, September 2018.

Ostrom QT, Cote D, Ascha M, et al, Adult Glioma Incidence and Survival by Race or Ethnicity in the United States From 2000 to 2014, JAMA Oncology, June 2018.

Kruchko C, Ostrom QT, Gittleman H, Barnholtz-Sloan JS. The CBTRUS story: providing accurate population-based statistics on brain and other central nervous system tumors for everyone, Neuro-Oncol (2018), March 2018.

Mendez JS, Ostrom QT, Gittleman, H, Kruchko C, DeAngelis LM, Barnholtz-Sloan JS, Grommes C, The elderly left behind-changes in survival trends of primary central nervous system lymphoma over the past 4 decades, Neuro-Oncology, February 2018.

Ostrom QT, Gittleman H, Stetson L, Virk S, Barnholtz-Sloan JS. Epidemiology of Intracranial Gliomas. Prog Neurol Surg. 2018;30:1-11. doi: 10.1159/000464374. Epub 2017 Dec 14. PubMed PMID: 29241168. December 2017.

Khanna V, Achey R, Ostrom Q T, Block-Beach H, Barnholtz-Sloan JS, de Blank PM, Incidence and Survival Trends for Medulloblastomas in the United States from 2001 to 2013, Journal of Neuro-Oncology, November 2017.

Ostrom QT, Gittleman H, Liao P, Vecchione-Koval T, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS, CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2010–2014, Neuro Oncol (2017) 19 (suppl 5): iv1-iv88, November 2017. 

Gittlemann H, Cote D, Ostron Q, Kruchko C, Smith T, Claus E, Barnholtz-Sloan JS.  Do race and age vary in non-malignant central nervous system tumor incidences in the United States? Journal of Neuro-Oncology, June 2017.

Achey R, Khanna V, Ostrom Q, Kruchko C, Barnholtz-Sloan J, Incidence and Survival Trends in Oligodendrogliomas and Anaplastic Oligodendrogliomas in the United States from 2000-2013. Journal of Neuro-Oncology June 2017.

Kromer C, Xu J, Ostrom Q, Gittleman H, Kruchko C, Sawaya R, Barnholtz-Sloan J, Frequency of synchronous brain metastases at time of primary cancer diagnosis in the US, 2010-2013 2017. Journal of Neuro-Oncology, J Neurooncol (2017), June 2017.

Kromer C, Ostrom Q, Blanda R, Gittleman M, Russell J, Kruchko C, Barnholtz-Sloan J, Is mortality due to primary malignant brain and other central nervous system tumors decreasing? J Neurooncol (2017), June 2017.

Zhang A, Ostrom QT, Kruchko C, Rogers L, Pereboom D, Barnholtz-Sloan JS.  Prevalence of Malignant Primary Brain Tumors in the United States Compared to other Common Cancers, 2010 Neuro Oncol (2016), December 2016.

Ostrom QT, Gittleman H, Xu J, Liu M, Kromer C, Wolinsky C, Kruchko C, Barnholtz-Sloan JS.  CBTRUS Statistical Report:  Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009-2013, Neuro Oncol (2016) 17 (suppl 5): iv1-iv76, November 2016.  

Li X-R, Kruchko C, Wu X-C, Hsieh M-C, Andrews A, Huang B, Wohler B, Are Benign and Borderline Brain Tumors Underreported? Journal of Registry Management, December 2016.

Chien LN, Gittleman H, Ostrom QT, Sloan AE, Kruchko C, Rogers LR, Wang YGW, Chiou HY, Barnholtz-Sloan JS.  Comparative Brain and Central Nervous System Tumor Incidence and Survival between the United States and Taiwan. Frontiers in Public Health, 21 July 2016 | http://dx.doi.org/10.3389/fpubh.2016.00151, July 2016.

Ostrom QT, Gittleman H, Kruchko C, Louis DN, Brat DJ, Gilbert MR, Petkov V, Barnholtz-Sloan JS, Completeness of required site-specific factors for brain and CNS tumors in the Surveillance, Epidemiology and End Results (SEER) 18 database (2004-2012,varying), J Neurooncol 2016, July 2016.
 
Farah P, Blanda R, Kromer C, Ostrom QT, Kruchko C, Barnholtz-Sloan JS. Conditional survival after diagnosis with malignant brain and CNS tumors in the US, Journal of Neuro-Oncology, 128(3), 419-429, DOI: 10.1007/s11060-016-2127-8, June 2016.
 
Rouse C, Gittleman H, Ostrom Q, Kruchko C, Barnholtz-Sloan J. Years of potential life lost for brain and central nervous system tumors relative to other cancer in adults in the United States, 2010. Neuro Oncol 2016 18(1). 70-77 doi: 10.1093/neuonc/nov249, January 2016  FUNDED under restricted Contract to Pediatric Brain Tumor Foundation.
 
Ostrom QT, Gittleman H, de Blank PM, Finlay JL, Gurney JG, McKean-Cowdin R, Stearns DS, Wolff JE, Liu M, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS, American Brain Tumor Association Adolescent and Young Adult Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2008-2012, Neuro Oncol 2015 18: i1-i50, in print January 2016 FUNDED under restricted Contract to American Brain Tumor Association. See link under Reports and Tables.
 
Ostrom QT, Gittleman H,  Fulop J, Liu M, Blanda R, Kromer C, Wolinsky Y, Kruchko C, and Barnholtz-Sloan JS, CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008–2012, Neuro Oncol (2015) 17 (suppl 4): iv1-iv62 doi: 10.1093/neuonc/nov189, in print November 2015.

Rice T, La Chance D, Molinaro AM, Eckel-Passow JE, Walsh KM, Barnholtz-Sloan JS, Ostrom QT, Francis S, Wiemels J, Jenkins R, Wienke, JK, Wrensch M. Understanding inherited genetic risk of glioma - a review. Neuro-Oncology Practice, March 23, 2015.

Kshettry VR, Hsieh JK, Ostrom QT, Kruchko C, Barnholtz-Sloan JS. Incidence of vestibular schwannomas in the United States. J Neurooncol. 2015 May 30. [Epub ahead of print] PubMed PMID: 26024654.

Kshettry VR, Hsieh JK, Ostrom QT, Kruchko C, Benzel EC, Barnholtz-Sloan JS. Descriptive Epidemiology of Spinal Meningiomas in the United States. Spine (Phila PA 1976). 2015 May 20. [Epub ahead of print] PubMed PMID: 25996535.

Kshettry VR, Ostrom QT, Kruchko C, Al-Mefty O, Barnett GH, Barnholtz-Sloan JS. Descriptive epidemiology of World Health Organization grades II and III intracranial meningiomas in the United States. Neuro Oncol. 2015 May 24. pii:nov069. [Epub ahead of print] PubMed PMID: 26008603.

Lym L, Ostrom QT, Kruchko C, Couce M, Brat DJ, Louis DN, Barnholtz-Sloan JS. Completeness and Consistency of WHO Grade Assignment for Brain and Central Nervous System Tumors in the United States, 2004-2011. J Neurooncol. Epub 2015 April 12.

De Blank PM, Ostrom QT, Rouse C, Wolinsky Y, Kruchko C, Salcido J, Barnholtz-Sloan JS. Years of life lived with disease and years of potential life lost in children who die of cancer in the United States, 2009. Cancer Med. 2015 Jan 27. Doi: 10.1002/cam4.410.

Woehrer A, Lau CC, Prayer D, Bauchet L, Rosenfeld M, Capper D, Fisher PG, Kool M, Muller M, Kros JM, Kruchko C, Wiemels J, Wrensch M, Danysh HE, Zouaoui S, Heck JE, Johnson KJ, Qi X, O’Neill BP, Afzal S, Scheurer ME, Bainbridge MN, Nousome D, Bahassi el M, Hainfeller JA, Barnholtz-Sloan JS. Brain Tumor Epidemiology - A Hub within Multidisciplinary Neuro-Oncology. Report on the 15th Brain Tumor Epidemiology Consortium (BTEC) Annual Meeting, Vienna, 2014. Clin Neuropathol. 2015 Jan-Feb; 34(1);40-6.

Ostrom QT, de Blank PM, Kruchko C, Peterson CM, Liao P, Finlay JL, Stearns DS, Wolff JE, Wolinsky Y, Letterio JJ, Barnholtz-Sloan JS. CBTRUS Statistical Report: Alex’s Lemonade Stand Foundation Infant and Childhood Primary Brain and Central Nervous System Tumor Diagnosed in the United States in 2007-2011. Neuro-Oncol. 2015 Jan; 16 Suppl 10: x1-x36. Doi: 10. 1093/neuonc/nou 327. FUNDED under restricted Contract to Alex’s Lemonade Stand Foundation. See link under Reports and Tables.

Gittleman H, Ostrom QT, Rouse CD, Dowling JA, de Blank PM, Kruchko CA, Elder JB, Rosenfeld SS, Seman WR, Sloan AE, Barnholtz-Sloan JS. Trends in central nervous system tumor incidence relative to other common cancers in adults, adolescents, and children in the United States, 2000-2010. Cancer 2015 Jan: 1(1): 102-112. Doi: 10.1002/cncr.29015. Epub 2014 Aug 25.

Ostrom QT, Gittleman H, Liao P, Rousse C. Chen Y, Dowling J, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011. Neuro-Oncol 2014 Nov; (sup 4): ii1-63.

Gittleman H, Ostrom QT, Farah PD, Ondracek A, Chen Y, Wolinsky Y, Kruchko C, Singer J, Kshettry VR, Laws ER, Sloan AE, Selman WR, Barnholtz-Sloan JS. Descriptive epidemiology of pituitary tumors in the United States, 2004-2009. J Neurosurg 2014 Sep; 121(3): 527-35. Doi: 10.3171/2014.5 JNS131819. Epub 2014 June 13.

Ostrom QT, Chen Y, de Blank PM, Ondracek A, Farah PD, Gittleman H, Wolinsky Y, Kruchko C, Cohen ML, Brat DJ, Barnholtz-Sloan JS. The descriptive epidemiology of atypical teratoid/rhabdoid tumors in the United States, 2001-2010. Neuro-Oncol 2014 Oct; 16(10): 1392-9. Doi: 10.1093/neuron/nou090. Epub 2014 May 20.

Ostrom QT, Gittleman H, Farah PD, Ondracek A, Chen Y, Wolinsky Y, Stroup NE, Kruchko C, Barnholtz-Sloan JS. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010. Neuro-Oncol 2013 Nov; (sup 2): ii1-56.

McCarthy BJ, Kruchko C, Dolecek TA, The Impact of the Benign Tumor Cancer Registries Amendment Act (Public Law 107-260) on Non-malignant Brain and Central Nervous System Tumor Incidence Trends. Journal of Registry Management, 40(1): 32-35, 2013.

Villano JL, Parker CK, Dolecek TA, Descriptive epidemiology of ependymal tumours in the United States. British Journal of Cancer. 108(11): 2367-2371, 2013.

McCarthy BJ, Shibui S, Kayama T, Miyaoka E, Narita Y, Murakami M, Matsuda A, Matsuda T, Sobue T, Palis BE, Dolecek TA, Kruchko C, Engelhard HH, Villano JL. Primary CNS Germ Cell Tumors in Japan and the United States: an Analysis of 4 Tumor Registries. Neuro Oncol. 2012 Sep;14(9):1194-200. doi: 10.1093/neuonc/nos155. Epub 2012 Aug 6.

Davis FG, Dolecek TA, McCarthy BJ, Villano JL. Toward Determining the Lifetime Occurrence of Metastatic Brain Tumors Estimated from 2007 United States Cancer Incidence Data. Neuro-Oncology, 2012 Sep;14(9):1171-7. doi: 10.1093/neuonc/nos152. Epub 2012 Aug 16.

Duong LM, McCarthy BJ, McLendon RE, Dolecek TA, Kruchko C, Douglas LL, Ajani UA. Descriptive Epidemiology of Malignant and Non-Malignant Primary Spinal Cord, Spinal Meninges, and Cauda Equina Tumors, United States, 2004–2007. Cancer. 2012 Sep 1;118(17):4220-7. doi: 10.1002/cncr.27390. Epub 2012 Jan 3.

Saraf S, McCarthy BJ, Villano, JL. Update on Meningiomas. Oncologist. 2011;16(11):1604-13. Epub 2011 Oct 25.

Koshy M, Villano JL, Dolecek TA, Howard A, Mahmood U, Chmura SJ, Weichselbaum RR, McCarthy BJ. Improved Survival Time Trends for Glioblastoma using the SEER 17 Population-Based Registries. Journal of Neuro-Oncology. 2012 Mar;107(1):207-12. Epub 2011 Oct 9.

Kohler BA, Ward E, McCarthy BJ, Schymura MJ, Ries LA, Eheman C, Jemal A, Anderson RN, Ajani UA, Edwards BK. Annual Report to the Nation on the Status of Cancer, 1975–2007, Featuring Tumors of the Brain and Other Nervous System. J Natl Cancer Inst. 103:714-736, 2011.

Porter KR, McCarthy BJ, Berbaum ML, Davis FG. Conditional Survival of All Primary Brain Tumor Patients by Age, Behavior, and Histology. Neuroepidemiology, 36(4):230-239, 2011.

Villano JL, Koshy M, Shaikh H, Dolecek TA, McCarthy BJ. Age, Gender and Racial Differences in Incidence and Survival in Primary CNS Lymphoma. British Journal of Cancer. 105(9):1414-8, 2011.

Porter KR, McCarthy BJ, Freels S, Kim Y, Davis FG. Prevalence Estimates for Primary Brain Tumors in the United States by Age, Gender, Behavior, and Histology. Neuro-Oncology, 12(6):520-527, 2010.

Villano JL, Bressler L, Propp JM, Valyi-Nagy T, Martin IK, Dolecek TA, McCarthy BJ. Descriptive Epidemiology of Selected Olfactory Tumors. Journal of Neuro-Oncology, 100(1):73-80, 2010.

Villano JL, Virk IY, Ramirez V, Propp JM, Engelhard HH, McCarthy BJ. Descriptive Epidemiology of Central Nervous System Germ Cell Tumors: Non-Pineal Analysis. Neuro-Oncology. 2010; 12:257-64.

McCarthy BJ, Schellinger KA, Propp JM, Kruchko C, Malmer B. A Case for the Worldwide Collection of Primary Benign Brain Tumors. Neuroepidemiology 33(3):268-275, 2009.

Curran EK, Le GM, Sainani KL, Propp JM, Fisher PG. Do Children and Adults Differ in Survival from Medulloblastoma? A Study from the SEER Registry. Journal of Neuro-Oncology 95(1):81-5, 2009.

Curran EK, Sainani KL, Le GM, Propp JM, Fischer PG. Gender Affects Survival from Medulloblastoma Only in Older Children and Adults: A Study from the Surveillance Epidemiology and End Results Registry. Pediatric Blood and Cancer 52(1):60-64, 2009.

McCarthy BJ, Propp JM, Davis FG, Burger PC. Time trends in oligodendroglial and astrocytic tumor incidence. Neuroepidemiology, 30:34-44, 2008.

Schellinger KA, Propp JM, Villano JL, McCarthy BJ. Descriptive epidemiology of primary spinal cord tumors. Journal of Neuro-Oncology, 87: 173-179, 2008.

Villano JL, Propp JM, Porter KR, Stewart AK, Valyi-Nagy T, Li X, Engelhard HE, McCarthy BJ. Malignant pineal germ cell tumors: An analysis of cases from three tumor registries. Neuro-Oncology, 10: 121-130, 2008.

Barnholtz–Sloan JS, Kruchko C. Meningiomas: causes and risk factors. Neurosurgical Focus, 23:E2, 2007.

Hoffman S, Schellinger KA, Propp JM, McCarthy BJ, Campbell RT, Davis FG. Seasonal variation in incidence of pediatric medulloblastoma in the United States, 1995–2001. Neuroepidemiology, 29:89–95, 2007.

Thuppal S, Propp JM, McCarthy BJ. Average years of potential life lost in those who have died from brain and CNS Tumors in the United States. Neuroepidemiology, 27: 22-27, 2006.

Hoffman S, Propp JM, McCarthy BJ. Temporal trends in incidence of primary brain tumors in the United States, 1985-1999. Neuro-Oncology [serial online], Doc. 05-032, December 5, 2005. URL <neuro-oncology.mc.duke.edu>

Propp JM, McCarthy BJ, Davis FG, Preston-Martin S. Descriptive epidemiology of vestibular schwannomas. Neuro-Oncology [serial online], Doc. 04-109, November 29, 2005. URL <neuro-oncology.mc.duke.edu>

McCarthy BJ, Kruchko C, and Central Brain Tumor Registry of the United States. Consensus conference on cancer registration of brain and central nervous system tumors. Neuro-Oncology, 7(2), 2005. (Posted to Neuro-Oncology [serial online], Doc. 04-050, February 11, 2005. URL <neuro-oncology.mc.duke.edu>)

Castillo MS, Davis FG, Surawicz T, Bruner JM, Bigner S, Coons S, Bigner DD. Consistency of primary brain tumor diagnoses and codes in cancer surveillance systems. Neuroepidemiology, 23:85-93, 2004.

McCarthy BJ, Surawicz T, Bruner JM, Kruchko C, Davis F. Consensus conference on brain tumor definition for registration. Neuro-Oncology. 4(2):134-145, 2002 (Posted to Neuro-Oncology [serial online], Doc. 01-059, February 21, 2002. URL <neuro-oncology.mc.duke.edu>)

Gershman ST, Surawicz TA, McLaughlin R, Rousseau D. Completeness of reporting of brain and other central nervous system neoplasms. Journal of Registry Management, 28:167-170, 2001.

Davis FG and McCarthy BJ. Current epidemiological trends and surveillance issues in brain tumors. Expert Review of Anticancer Therapy, 1:395-401, 2001.

Davis FG, Kupelian V, Freels S, McCarthy B, Surawicz T. Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups. Neuro-Oncology, 3:152-158, 2001. (Posted to Neuro-Oncology [serial online], Doc. 00-056, June 5, 2001. URL<neuro-oncology.mc.duke.edu>)

Jukich PJ, McCarthy BJ, Surawicz TS, Freels S, Davis FG. Trends in incidence of primary brain tumors in the United States, 1985-1994. Neuro-Oncology, 3:141-151, 2001. (Posted to Neuro-Oncology [serial online], Doc. 00-055, June 5, 2001. URL<neuro-oncology.mc.duke.edu>)

Surawicz TS, Kupelian VA, Davis FG. Changes in age-adjusted disease incidence using the year 2000 standard population: an example using data from the Central Brain Tumor Registry of the United States. Journal of Registry Management, 28:6164, 2001.

Davis FG and McCarthy BJ. Epidemiology of brain tumors. Current Opinion in Neurology, 13:635-640, 2000.

Surawicz TS, McCarthy BJ, Jukich PJ, Davis FG. The accuracy and completeness of primary brain and central nervous system tumor data: results from the Central Brain Tumor Registry of the United States. Journal of Registry Management, 27:5155, 2000.

Davis FG, McCarthy B, Jukich P. The descriptive epidemiology of brain tumors. Neuroimaging Clinics of North America, 9:581-594, 1999.

Surawicz TS, McCarthy BJ, Kupelian V, Jukich PJ, Bruner JM, Davis FG. Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990-1994. Neuro-Oncology, 1:14-25, 1999. (Posted to Neuro-Oncology [serial online], Doc. 98-04, January 19, 1999. URL <neuro-oncology.mc.duke.edu>)

Davis FG, McCarthy BJ, Freels S, Kupelian V, Bondy ML. The conditional probability of survival of patients with primary malignant brain tumors: Surveillance, Epidemiology, and End Results (SEER) data. Cancer, 85:485-491, 1999.

Gurney JG, Wall DA, Jukich PJ, Davis FG. The contribution of nonmalignant tumors to CNS tumor incidence rates among children in the United States. Cancer Causes and Control, 10:101-105, 1999.

Surawicz TS, Davis F, Freels S, Laws ER Jr, Menck HR. Brain tumor survival: results from the National Cancer Data Base. Journal of Neuro-Oncology, 40:151-160, 1998.

Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM. The descriptive epidemiology of craniopharyngioma. Journal of Neurosurgery, 89:547-551, 1998.

McCarthy BJ, Davis FG, Freels S, Surawicz TS, Damek DM, Grutsch J, Menck HR, Laws ER Jr. Factors associated with survival in patients with meningioma. Journal of Neurosurgery, 88:831-839, 1998.

Davis FG, Freels S, Grutsch J, Barlas S, Brem S. Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 19731991. Journal of Neurosurgery, 88:1-10, 1998.

Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM. The descriptive epidemiology of craniopharyngioma. Neurosurgical Focus, 3(6):Article 1, December 1997.

McCarthy BJ, Davis F, Freels S, Surawicz TS, Damek D, Grutsch J, Menck HR, Laws ER Jr. Factors associated with survival in patients with meningioma. Neurosurgical Focus, 2(4):Article 1, April 1997.

Davis FG, Bruner JM, Surawicz TS. The rationale for standardized registration and reporting of brain and central nervous system tumors in population-based cancer registries. Neuroepidemiology, 16:308-316, 1997.

Davis FG, Malinski N, Haenszel W, Chang J, Flannery J, Gershman S, Dibble R, Bigner DD. Primary brain tumor incidence rates in four United States regions, 1985-1989: a pilot study. Neuroepidemiology, 15:103-112, 1996.